Clinical Trials Browser

Small Cell Lung Carcinoma × sintilimab × Clear all

NCT04192682 2020-01-06

Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer

Phase 2/3 Unknown

Small Cell Lung Carcinoma

NCT04056949 2019-08-14

Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide Chemotherapy

Phase 2 Unknown

Small Cell Lung Carcinoma